Herpes Simplex Virus (HSV) The 5 Minute Pediatric Consult
Herpes Simplex Virus (HSV)

Jane M. Gould

Database
Differential Diagnosis
Data Gathering
Laboratory Aids
Therapy
Follow-Up
Common Questions and Answers
Bibliography

DATABASE

DEFINITION

Herpes simplex virus (HSV) is a moderately large double-stranded DNA virus. There are two serologically distinguishable subtypes: HSV-1 and HSV-2. HSV produces a wide spectrum of illness ranging from fever blisters to fatal viral encephalitis.

PATHOPHYSIOLOGY

EPIDEMIOLOGY

ASSOCIATED DISEASES

DIFFERENTIAL DIAGNOSIS
DATA GATHERING

HISTORY

Neonatal Infection

Gingivostomatitis

Encephalitis

Vulvovaginitis

LABORATORY AIDS

Neonatal Infection

Encephalitis

Gingivostomatitis

Physicians usually make this diagnosis clinically since it is so common in young children.

Vulvovaginitis

THERAPY

NEONATAL INFECTION

Intravenous acyclovir (30 mg/kg/d in 3 divided doses) is the preferred drug. Some experts give higher doses (45–60 mg/kg/d). The recommended minimal duration of therapy is 14 days, and sometimes courses as long as 21 days may be indicated. Infants with ocular involvement due to HSV infection should receive a topical ophthalmic drug (1–2% trifluridine, 1% iododeoxyuridine, or 3% vidarabine) in addition to parenteral antiviral therapy.

ENCEPHALITIS

Intravenous acyclovir (30 mg/kg/d) three times a day for 14–21 days is appropriate therapy for HSV encephalitis after the neonatal period. In addition to parenteral antiviral therapy appropriate management of fluids, intracranial pressure, and seizures is essential.

GINGIVOSTOMATITIS

Most patients are managed with symptomatic therapy including antipyretics and oral fluids like popsicles. Oral anesthetics can be harmful and result in self injury when children chew on anesthetized lips. Topical acyclovir is often used in the treatment of recurrent oral herpes. It decreases the duration of HSV shedding but has minimal effect on the symptoms.

VULVOVAGINITIS

Acyclovir (Zovirax) is the appropriate therapy for genital herpes infection. Oral acyclovir is used for patients with primary genital HSV infection. Intravenous acyclovir is used for patients with severe local or systemic or complications like aseptic meningitis syndrome.

FOLLOW-UP

PREVENTION

PROGNOSIS

COMMON QUESTIONS AND ANSWERS

Q: What about recurrent cutaneous eruptions in a neonate? Should they be treated?
A: The need for retreatment of infants with recurrent skin lesions is undetermined and under study. Because of concerns about silent CNS recurrent infection, some experts are recommending acyclovir, 300 mg/m2 in three doses for 6–12 months. One needs to look for neutropenia, which will occur in 25% of patients.

Q: Is prophylactic therapy for recurrent herpes genitalia helpful? When is it indicated?
A: Antiviral therapy has minimal effect on recurrent genital herpes. Oral acyclovir initiated within 2 days of onset of symptoms shortens the course. Topical acyclovir is not helpful.

Q: What steps should be taken in the nursery for an infant born to an HSV-positive mother?
A: Neonates with documented perinatal exposure to HSV may be in the incubation phase of infection and should be observed carefully. Infants of mothers with active HSV should be isolated if they have been delivered vaginally or by cesarean section after membranes were ruptured for more than 4–6 hours. The risk of HSV infection in possibly exposed infants (e.g., those born to a mother with a history of recurrent genital herpes) is low, and isolation is not necessary.

ICD-9-CM 054.9

BIBLIOGRAPHY

Corey L, Adams HG, Brown ZA, et al. Genital herpes simplex virus infections, clinical manifestations, course, and complications. Ann Intern Med 1983;98:958–972.

Corey L, Spear PG. Infections with herpes simplex virus. N Engl J Med 1986;314:686–691, 749–757.

Emans SJ, Goldstein DP. Vulvovaginal complaints in the adolescent in pediatric and adolescent gynecology, 3rd ed. Boston: Little, Brown, 1990:307–343.

Kohl S. Postnatal herpes simplex virus infection. In: Feigin RD, Cherry JD, eds. Pediatric infectious diseases, 3rd ed. Philadelphia: WB Saunders, 1992:1558–1583.

Marshall GS. Epidemiology and clinical manifestations of herpes infections in infants and children. Semin Pediatr Infect Dis 1997;8:151–168.

Nahmias AJ, Keyserling HL, Kevich GM. Herpes simplex. In: Remington JS, Klein JU, eds. Infectious diseases of the fetus and newborn infant, 2nd ed. Philadelphia: WB Saunders, 1983:636–678.

Nahmias AJ, Whitley RJ, Herpes simplex virus encephalitis in pediatrics. Pediatr Rev 1981;2:259–266.

Whitley RJ. Kimberlin DW. Treatment of viral infections during pregnancy and the neonatal period. Clin Perinatol 1997;24(1):267–283.


Copyright
© 2000 Lippincott Williams & Wilkins
M. William Schwartz, Louis M. Bell, Jr., Peter M. Bingham, Esther K. Chung, David F. Friedman and Andrew E. Mulberg, The 5 Minute Pediatric Consult

Hosted by www.Geocities.ws

1